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Abstract  
Exposure to DNA-damaging agents produces a range of stress-related responses. 
These change the expression of genes leading to mutations that cause cell cycle 
arrest, induction of apoptosis and cancer. We have examined the contribution of 
haploid and diploid DNA damage and genes involved in the regulation of the 
apoptotic process associated with exposure, The Comet assay was used to detect 
DNA damage and quantitative RT-PCR analysis (qPCR) to detect gene expression 
changes in lymphocytes and sperm in response to methyl methanesulfonate. In the 
Comet assay, cells were administered 0 -1.2 mM of MMS at 37 ºC for 30 min for 
lymphocytes and 32 ºC for 60 min for sperm to obtain optimal survival for both cell 
types. In the Comet assay a significant increase in Olive tail moment (OTM) and % 
tail DNA indicated DNA damage at increasing concentrations compared to the 
control group. In the qPCR study, cells were treated for 4 h, and RNA was isolated at 
the end of the treatment. qPCR analysis of genes associated with DNA stress 
responses showed that TP53 and CDKN1A are upregulated, while BCL2 is 
downregulated compared with the control. Thus, MMS caused DNA damage in 
lymphocytes at increasing concentrations, but appeared not to have the same effect 
in sperm at the low concentrations. These results indicate that exposure to MMS 
increased DNA damage and triggered the apoptotic response by activating TP53, 
CDKN1A and BCL2. These findings of the processing of DNA damage in human 
lymphocytes and sperm should be taken into account when genotoxic alterations in 
both cell types are produced when monitoring human exposure. 
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Introduction  
The alkaline Comet assay is widely used for human biomonitoring, ecotoxicology 
and routine genotoxicity assessment of chemicals. It has been used extensively to 
assess DNA damage as single and double strand breaks and alkali‐labile sites in the 
whole genome of the individual cells (Anderson and Plewa 1998; Tice et al. 
2000).The connections between cell cycle and cell death have been studied and it 
has been commonly found that cycling cells are more vulnerable to apoptosis, while 
inactive cells are comparatively more resistant to killing (Pucci, Kasten, and 
Giordano 2000). It is known that cancer treatments recruit additional cells into the 
commonly small growth fraction of the tumour, so that cells could be vulnerable to 
chemotherapeutic drugs (Hardwick and Soane 2013). Cells treated with the 
methylating agent methyl methanesulfonate (MMS) results in alkylated DNA that is 
badly replicated via DNA polymerases in vitro and in vivo (Tercero and Diffley 2001). 
This DNA damage induced via genotoxic stress leads to changes in the expression 
of several critical genes. The TP53 gene is the most relevant of these genes, also 
known as tumour protein 53, which encodes for a 393 amino acid nuclear protein 
that functions as a transcription factor p53 (Soussi, Caron de Fromentel, and May 
1990). The p53 tumour suppressor gene is important and included in cell cycle 
regulation, detection and repair of DNA damage, apoptosis and senescence 
(Hamzehloie et al. 2012). The ability of p53 to induce senescence or apoptosis of 
cells exposed to oncogenic stress establishes a main pathway by which p53 
functions as a tumour suppressor (Pietsch et al. 2008). Over the past several 
decades, researcher revealed that the p53 protein is superfluous for normal progress 
but is essential in cellular response to DNA damage (Liu and Kulesz-Martin 2001; 
Liu, Chung, et al. 2010). The activity of p53 is firmly controlled at insignificant levels 
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in normal cells. p53 protein is rapidly induced by DNA damaging stimuli such as UV 
light, chemical carcinogens and chemotherapeutic agents (Liu and Kulesz-Martin 
2001; Purvis et al. 2012). The induction of p53 is attained during a post-translational 
mechanism which decreases the p53 turnover. This p53 induction plays a crucial 
role in transcriptional activation of the cell cycle inhibitor p21 and cell cycle arrest 
(Wulf et al. 2002). The cyclin-dependent kinase (CDK) inhibitor p21CDKN1A  is mostly 
controlled at the transcriptional level, while induction of p21 mainly leads to cell cycle 
arrest (Gartel and Radhakrishnan 2005). In addition, p21 plays an important role by 
inhibition of DNA replication during relation with the proliferation of the cell nuclear 
antigen PCNA (Perucca et al. 2006). The level of expression of p21 is up-regulated 
via the p53 tumour suppressor gene in vitro, in response to DNA-damaging agents 
(Macleod et al. 1995; Benson et al. 2014). p21 mediates growth arrest when cells 
are exposed to DNA damaging agents such as chemotherapy drugs (Gartel and 
Radhakrishnan 2005). Furthermore, p21 expression can be regulated p53 
independently in several situations involving cellular differentiation and normal tissue 
development (Liu, Hou, et al. 2010). The members of the Bcl-2 family of proteins are 
included in the regulation of apoptosis pathways as inducer and inhibitor in many cell 
types (Hardwick and Soane 2013). They are regulated and mediate the process by 
which mitochondria contribute to cell death. This pathway is required for normal 
embryonic development and for preventing cancer (Hardwick and Soane 2013). The 
Bcl2 protein also has important roles in normal cell physiology associated with 
mitochondrial dynamics and other processes of normal healthy cells (Hardwick and 
Soane 2013). 
In the present study, DNA damage was assessed using the Comet assay. The 
expression of the apoptosis regulatory genes, TP53, CDKN1A and BCL2 were 
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determined using qPCR methods in somatic and germ cells after MMS treatment of 
human lymphocytes and sperm to determine effects in diploid and haploid cells.  
Materials and Methods 
Collection of semen and blood samples  
Ethical approval for the collection of semen and blood samples has been provided by 
the University of Bradford’s Research Ethics Subcommittee involving human 
subjects (reference number: 0405/8). After informed consent, peripheral blood from 
four healthy, non-smoking volunteers (average age of 38 ± 6.7 years) was obtained 
in heparinised vacutainers (Greiner-Bio-One, Germany) by venepuncture. Also, four 
semen samples were provided and consented and each sample was analysed within 
2 h after ejaculation according to the WHO criteria (World Health Organization, 1999) 
for general appearance, viscosity, volume, pH, sperm concentration, motility and 
morphology. After aliquoting, semen samples were snap-frozen in liquid nitrogen and 
subsequently stored at −80 ◦C until analysis. 
Lymphocyte isolation for the Comet assay 
Whole blood was diluted 1:1 with saline and lymphocytes were isolated using of 
Lymphoprep (Axis-Shield, Norway) according to the manufacturer’s instructions. The 
lymphocyte pellet was then resuspended in foetal bovine serum (FBS; Invitrogen, 
UK) and transferred to a cryovials containing FBS/DMSO (9:1). This cell suspension 
was frozen at −20 ◦C overnight and then transferred to −80 ◦C for storage before 
use. 
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Cell treatment  
Cell suspensions (1 ml, 106 cells/ml) were mixed with fresh Roswell Park Memorial 
Institute (RPMI) 1640 Medium (total volume 1000 µl). One hundred μl of cell 
suspension were then added to each treatment tube with, 890 μl RPMI medium, plus 
10 μl of MMS or RPMI for the negative control). Cells were treated with different 
concentrations (0, 0.3, 0.6, 0.8 and 1 mM) of MMS for 30 min at 37 ◦C (lymphocytes) 
or for 60 min at 32 ◦C (sperm). The treated and untreated cells were used for the 
Comet assay and quantitative reverse transcription PCR (RT-qPCR). 
Cell viabilities 
To prevent the effect of DNA degradation related to cytotoxicity, viability staining of 
lymphocytes was performed prior to the experiments (Tice et al. 2000). For both 
lymphocytes and sperm, cell viability was measured by use of the Trypan blue 
exclusion test (10 µl of 0.05% Trypan blue added to 10 µl of cell suspension (Pool-
Zobel et al. 1992). Viability was generally >90%, but always >75% (Henderson et al. 
1998).   
Comet assay on sperm and lymphocytes  
DNA damage was measured with the alkaline version of the Comet assay. In brief, 
after treatment, cell samples were centrifuged and the supernatant was discarded. 
To the cell pellet 100 μl of 0.5% low melting agarose (LMP) (Invitrogen, Paisley, UK: 
15517-022) was added. This cell suspension was transferred to slides pre-coated 
with 1% normal melting point (NMP) agarose. For sperm, 2% LMP agarose was 
used. The slides were placed on an ice block for 5 min, after which 100 μl of 0.5% 
LMP was added on top and slides were placed on ice for another 5 min. When using 
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lymphocytes, slides were placed in freshly prepared, cold lysing buffer (2.5 M NaCl, 
100 mM EDTA, 10 mM Tris, pH 10, with 1% Triton X-100 and 10% DMSO added just 
before use) and kept overnight at 4◦C. For sperm, the lysis solution was 
supplemented with 10 mM dithiothreitol (Sigma, UK) and 0.05 g/ml proteinase K 
(Sigma, UK), respectively, and incubation took place in each solution for 1 h at 4 ◦C. 
The slides were placed on a horizontal gel electrophoresis platform and covered with 
an alkaline solution of 300 mM NaOH and 1 mM Na2EDTA, pH ∼13.5) for a pre-
incubation prior to electrophoresis. Electrophoresis was carried out for 30 min 
(lymphocytes) or 20 min (spermatozoa) at 4 ◦C at ∼0.75 V/cm (20-25V, ∼300 mA). 
The DNA was electrophoresed for 20 min and the slides rinsed gently 3 times with 
400 mM Tris (pH 7.5) to neutralize the excess alkali. Each slide was stained with 60 
μl of 20 µg/ml ethidium bromide (Sigma) and covered with a coverslip. Slides were 
analyzed by a computerized image analysis system (Comet 6.0; Andor Technology, 
Belfast, UK). In the Comet assay, Olive tail moment and % tail DNA were measured 
as DNA damage parameters for sperm and lymphocytes. All of these steps were 
conducted under dimmed light to prevent the occurrence of additional DNA damage.  
Isolation of total RNA and cDNA synthesis 
Total RNA from cells (lymphocytes and sperm) was isolated using TRIzol® following 
the manufacturer's (Invitrogen) manual and RNA quantity and quality were checked 
by OD260/280 measurements. To remove any genomic DNA, the RNA was treated 
with DNase I (Sigma–Aldrich) according to the manufacturer's instructions. Random 
hexamer primed reverse transcription reactions were performed for 400 ng of total 
RNA in a 20 μl setup using ImProm-II™ Reverse Transcription System reaction 
following the manufacturer's instructions (Promega). The synthesised cDNA samples 
were diluted 1:10 in nuclease free water and stored at −20 °C. 
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Quantitative real-time PCR assay 
Reactions were carried out using the StepOnePlus™ real-time PCR instrument 
(Applied Biosystems). Quantitative real-time PCR was used to quantify the mRNA 
expression of TP53, CDKN1A and BCL2 in lymphocytes and sperm. QPCR was 
prepared in triplicates of 20 μl reaction mixture in MicroAmp optical 96-well reaction 
plates and sealed with optical adhesive covers (Applied Biosystems). Each reaction 
well contained 2 μl of template DNA, 2 μl of 10 × SYBR® Green PCR Master Mix 
(Applied Biosystems), and 12.5 pmol each of forward and reverse primers. Real-time 
qPCR was conducted with the following cycling conditions: 50 °C for 2 min, 95 °C for 
20 s, followed by 50 cycles of 95 °C for 15 s and 60 °C for 30 s each. The data 
obtained from each reaction was analysed by StepOne™ Software v 2.2.2. Relative 
quantification representing the change in gene expression from real-time quantitative 
polymerase chain reaction between experimental groups was calculated by the 
comparative CT method. The data were analysed by calculating the relative 
quantification (RQ) using the equation: RQ = 2-∆CT x100, where ∆CT = CT of target 
gene- CT of an endogenous housekeeping gene. Evaluation of 2
-∆CT indicates the fold 
change in gene expression, normalized to the internal control (β-actin) which enables 
the comparison between differently treated cells. 
Results  
The responses of human lymphocytes to MMS for the Comet assay parameters 
Olive tail moment (OTM) and percent DNA in tail (% tail DNA) are shown in Table 1, 
Figures 1 and 2. A significant increase was seen in tail moment and % tail DNA in 
the lymphocytes from 5.70 (OTM) and 22.42% (% tail DNA) compared to the 
untreated control groups to 1.49 (OTM) 7.65% (% tail DNA), respectively, when cells 
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were treated with 0.6 mM MMS. Further increases to 6.97 in (OTM) and 27.57% in 
(% tail DNA) were observed when cells were treated with 0.8 mM MMS. At 1.2 mM, 
in the OTM and % tail DNA further increased to 11.00 and 36.71% respectively. For 
sperm, the corresponding mean tail moments increased from 4.93 in control to 6.28 
at 0.3 mM and 8.44 at 0.6 mM. After treatment, significant increases in tail moment 
of the nuclei were seen (Table 1, Figures 1 and 2). This significant increase 
remained at approximately the same level in OTM to a final concentration of 1.2 mM 
MMS. The same significant MMS induction of DNA damage could also be seen 
when the % tail DNA was considered, as increases from 27.98 % in control to 
34.68% (at 0.3 mM) and 39.60% (at 0.6 mM) were observed. Following exposure to 
0.8 mM, cells treated with 0.8 mM MMS showed statistically significant increased % 
tail DNA damage to 46.61%, when compared with the control. A further increase to 
51.15% in % tail DNA was observed when cells were treated with 1 mM MMS. 
For the qPCR assay, different levels of expression of TP53, CDKN1A and BCL2 
mRNA in lymphocytes were seen after treatment with different concentrations of 
MMS. The samples were taken at 4 h following MMS treatment for both treated and 
untreated control cultures, and the expression levels of TP53, CDKN1A and BCL2 
were normalised against those of β-actin and compared with the equivalent control 
value.  
Figures 3 and 4 shows RT-PCR results of different apoptotic genes after 
lymphocytes and sperm cells were treated with MMS. When the MMS concentration 
was increased from 0 to 1.2 mM, the band intensities for TP53 and CDKN1A were 
found to be increased while the intensities for bands of BCL2 were found to be 
decreased with the increased MMS concentration. To ensure even loading of the 
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total proteins, the β-actin was used. Figure 3 B and 4 B show mRNA expression of 
TP53 and CDKN1A, and BCL2 in human lymphocytes. The expression levels of 
these genes were evaluated by the qPCR. 
There were statistically significant differences in the levels of TP53 and CDKN1A 
after 4h of treatment with 0.3, 0.6, 0.8 mM and 1.2 mM MMS in both lymphocytes 
and sperm. However, a significant decrease in the level of expression of BCL2 in 
both cells treated with 0.3, 0.6, 0.8 mM and 1.2 mM MMS (*p 0.05, **p 0.01 and***p 
0.001) and respectively as shown in Figures 3 A and B and 4 A and B. 
Discussion  
Methyl methanesulfonate was the chemical of choice for the induction of DNA 
damage in human lymphocytes and sperm as a well-known genotoxic compound 
that can directly react with guanine and adenine bases of DNA to generate 
interstrand and intrastrand cross-links (Hosseinimehr et al. 2011). During cell 
division, however, the replication fork could be stalled and collapses at the sites of 
DNA cross-links, leading to formation and subsequent processing of DNA double 
strand-breaks (DSB), which are considered the most deleterious form of DNA 
damage (Yu et al. 2006). Through obstructing the structural and functional properties 
of DNA, DSBs can have deleterious effects on many aspects of DNA metabolism, 
including DNA replication and transcription, and because they can eventually cause 
mutations and chromosomal aberrations (Shanbhag et al. 2010; Polo and Jackson 
2011). DSBs can also create various signal transduction pathways that can 
ultimately result in cell tumorigenesis, to programmed cell death (Suwaki, Klare, and 
Tarsounas 2011). These DNA strand breaks inducing programmed cell death is a 
crucial event for numerous regular chemotherapeutic agent applications (Waxman 
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and Schwartz 2003). Programmed DNA lesions also form as intermediates through 
developmentally regulated genome rearrangements in germ cells and somatic cells 
(Tsai and Lieber 2010; Longhese et al. 2009).The induction of DNA breaks and the 
changed expression of the apoptosis regulatory genes, TP53, CDKN1A and BCL2 
by MMS were assessed using the comet and qPCR assays on human lymphocytes 
and sperm. For the Comet assay, DNA damage response patterns for the OTM and 
% tail DNA Comet-assay parameters were observed for both cell types (Tables 1 
and 2); however, sperm additionally showed a significant increase in OTM and % tail 
DNA after being exposed to lower concentrations of 0.3 mM for both OTM and % tail 
DNA (Figure1). MMS genotoxicity on germ cells has been well studied and described 
in numerous in vivo studies reporting the induction of chromatin alterations also 
dominant lethal mutations and heritable translocations in sperm (Russell et al. 1992; 
Ehling and Neuhauser-Klaus 1990; Cordelli et al. 2007). This suggests that the 
damage to the spermatozoa DNA was potentially introduced by inhibiting replication, 
causing formation of replication-related to DNA lesions, and potentially double-strand 
breaks. Late spermatids and immature spermatozoa are most sensitive to MMS due 
to the absence of DNA repair during postmeiotic stages (Inoue et al. 1993). MMS 
also showed significantly increased concentration-dependent responses in 
lymphocytes for the Comet assay parameters. OTM values significantly increased 
with the MMS concentration of 0.6 mM. This significant increase continued to stay at 
approximately the same level up to concentrations of 0.8 mM and 1.2 mM MMS 
(Table 1). This positive result is similar to results of Baohong et al. (2005), where 
earlier significantly increased incidences of DNA damage were observed in human 
lymphocytes after in vitro treatment with MMS using the Comet assay (Baohong et 
al. 2005). Our results show that sperm reach significance at a lower threshold of 
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sensitivity with lower concentrations of MMS. This may be due to the fact that they 
are unable to repair damaged DNA and they are structurally different. This has been 
previously shown for others chemicals (Baumgartner et al. 2012). In another study, it 
has been reported that DNA damage was evaluated in human lymphocytes and 
sperm, highly increased DNA damage in sperm was observed when compared with 
the response in lymphocytes using the alkaline comet assay in vitro (Anderson et al. 
2003; Pandir 2015; Migliore et al. 2006). In contrast to somatic cells, sperm 
protamines contain a significant number of cysteine residues which are essential in 
the last stage of sperm nuclear maturation as they form protamine disulfide cross 
bonds (Loir and Lanneau 1984). This S-methyl-L-cysteine group is the major 
reaction product after exposure to MMS (Sega and Owens 1983). Alkylation of 
cysteine sulfhydryl groups contained in sperm protamine blocks normal disulfide 
bond formation, preventing proper chromatin condensation in the sperm nucleus. 
Subsequent stresses produced in the chromatin structure eventually lead to 
chromosome breakage, with resultant dominant lethality (Sega and Owens 1983). 
The results also showed that the defective spermatid protamination and disulphide 
bridge formation could be attributable to insufficient oxidation of alkylation groups. 
This destructively affects sperm chromatin packaging and creates sperm cells more 
susceptible to reactive oxygen species (ROS) while subsequently inducing DNA 
fragmentation. Lymphocytes, however, seem to be less susceptible to MMS during 
the cell cycle. This implies that less damage to the DNA from lymphocyte was seen 
due to repair of DNA damage before replication start. Fast repair of DNA damage 
was observed in human lymphocytes during the first hours of cultivation after 
treatment with MMS using the comet assay (Bausinger and Speit 2015). Mammalian 
cell responses to several stresses fluctuate importantly; reliant on the type of cells 
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exposed to stress and time and type of toxicant exposure. MMS induces apoptosis 
during the activation of p53-dependent and independent pathways (Lackinger, 
Eichhorn, and Kaina 2001; Ryu et al. 2001). In agreement with these studies, our 
data showed that for both cell types, after 4h treatment with MMS (0.3, 0.6, 0.8 and 
1.2 mM), TP53 and CDKN1A were induced and BCL2 expression was 
downregulated in a dose dependent manner. The p53 plays a key role in the 
regulation of cell cycle events (Sionov, Hayon, and Haupt 2000). In response to DNA 
damage, p53 is activated and turns on the transcription of one of its important 
downstream genes, p21 (el-Deiry et al. 1993). p21 subsequently binds and inhibits, 
preventing phosphorylation of important CDK substrates and blocking cell cycle 
development, so allowing further time for the cell to repair DNA damage (Ouhtit et al. 
2000). Our findings that MMS induction of TP53 led to the induction of the CDKN1A 
gene (Figures 3 and 4) implies that MMS induces TP53, which, in turn, activates 
CDKN1A and results in cell cycle arrest to allow the repair of induced DNA 
damage. These results, also combined with the disruption of mitochondrial 
membrane permeabilization, release of cytochrome c from mitochondria, and 
downregulation of BLC2, indicate that the accumulation of DSB contributes to the 
induction of mitochondria-dependent cell apoptosis under these experimental 
conditions.  
Conclusions 
The present study reveals the effects of MMS on human somatic cells and germ 
cells and provides significant insight into potential mechanisms through which MMS 
exerts its genotoxic effects on these cells. In addition to the Comet assay data 
evaluation of DNA damage via qPCR data using differential expression analysis of 
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TP53, CDKN1A and BCL2 genes have provided the evidence for the genotoxic 
effects of MMS in healthy human lymphocytes and sperm. Thus, the sperm appear 
to be more sensitive to MMS. Despite the differences in cell packaging of the two cell 
types, they were examined at optimal conditions of survival for both types, so can 
more readily be made. 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
 
Acknowledgement 
The Sponsorship of the Libyan Government of a PhD studentship to Khaled Habas is 
gratefully acknowledged. The Sponsor played no part in the conduct of the work or 
the writing of the manuscript. 
Conflict of Interest Statement 
The authors have no conflicts of interest with regard to the funding of this research. 
 
 
 
 
 
 
 
 
 
 
 
16 
 
 
References  
Anderson, D., and M. J. Plewa. 1998. The International Comet Assay Workshop. Mutagenesis 13 
(1):67-73. 
Anderson, D., T. E. Schmid, A. Baumgartner, E. Cemeli-Carratala, M. H. Brinkworth, and J. M. Wood. 
2003. Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the 
Comet assay). Mutat Res 544 (2-3):173-8. 
Baohong, W., H. Jiliang, J. Lifen, L. Deqiang, Z. Wei, L. Jianlin, and D. Hongping. 2005. Studying the 
synergistic damage effects induced by 1.8 GHz radiofrequency field radiation (RFR) with four 
chemical mutagens on human lymphocyte DNA using comet assay in vitro. Mutat Res 578 (1-
2):149-57. 
Baumgartner, A., M. Kurzawa-Zegota, J. Laubenthal, E. Cemeli, and D. Anderson. 2012. Comet-assay 
parameters as rapid biomarkers of exposure to dietary/environmental compounds -- an in 
vitro feasibility study on spermatozoa and lymphocytes. Mutat Res 743 (1-2):25-35. 
Bausinger, J., and G. Speit. 2015. DNA repair capacity of cultured human lymphocytes exposed to 
mutagens measured by the comet assay and array expression analysis. Mutagenesis. 
Benson, E. K., S. K. Mungamuri, O. Attie, M. Kracikova, R. Sachidanandam, J. J. Manfredi, and S. A. 
Aaronson. 2014. p53-dependent gene repression through p21 is mediated by recruitment of 
E2F4 repression complexes. Oncogene 33 (30):3959-69. 
Cordelli, E., A. M. Fresegna, A. D'Alessio, P. Eleuteri, M. Spano, F. Pacchierotti, and P. Villani. 2007. 
ReProComet: a new in vitro method to assess DNA damage in mammalian sperm. Toxicol Sci 
99 (2):545-52. 
Ehling, U. H., and A. Neuhauser-Klaus. 1990. Induction of specific-locus and dominant lethal 
mutations in male mice in the low dose range by methyl methanesulfonate (MMS). Mutat 
Res 230 (1):61-70. 
el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. 
W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. 
Cell 75 (4):817-25. 
Gartel, A. L., and S. K. Radhakrishnan. 2005. Lost in transcription: p21 repression, mechanisms, and 
consequences. Cancer Res 65 (10):3980-5. 
Hamzehloie, T., M. Mojarrad, M. Hasanzadeh Nazarabadi, and S. Shekouhi. 2012. The role of tumor 
protein 53 mutations in common human cancers and targeting the murine double minute 2-
p53 interaction for cancer therapy. Iran J Med Sci 37 (1):3-8. 
Hardwick, J. M., and L. Soane. 2013. Multiple functions of BCL-2 family proteins. Cold Spring Harb 
Perspect Biol 5 (2). 
Henderson, L., A. Wolfreys, J. Fedyk, C. Bourner, and S. Windebank. 1998. The ability of the Comet 
assay to discriminate between genotoxins and cytotoxins. Mutagenesis 13 (1):89-94. 
Hosseinimehr, S. J., M. Azadbakht, M. Tanha, A. Mahmodzadeh, and S. Mohammadifar. 2011. 
Protective effect of hawthorn extract against genotoxicity induced by methyl 
methanesulfonate in human lymphocytes. Toxicol Ind Health 27 (4):363-9. 
Inoue, M., T. Kurihara, M. Yamashita, and K. Tatsumi. 1993. Effects of treatment with methyl 
methanesulfonate during meiotic and postmeiotic stages and maturation of spermatozoa in 
mice. Mutat Res 294 (2):179-86. 
Lackinger, D., U. Eichhorn, and B. Kaina. 2001. Effect of ultraviolet light, methyl methanesulfonate 
and ionizing radiation on the genotoxic response and apoptosis of mouse fibroblasts lacking 
c-Fos, p53 or both. Mutagenesis 16 (3):233-41. 
Liu, J. J., T. K. Chung, J. Li, and R. Taneja. 2010. Sharp-1 modulates the cellular response to DNA 
damage. FEBS Lett 584 (3):619-24. 
17 
 
Liu, S., W. Hou, P. Yao, B. Zhang, S. Sun, A. K. Nussler, and L. Liu. 2010. Quercetin protects against 
ethanol-induced oxidative damage in rat primary hepatocytes. Toxicol In Vitro 24 (2):516-22. 
Liu, Y., and M. Kulesz-Martin. 2001. p53 protein at the hub of cellular DNA damage response 
pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis 
22 (6):851-60. 
Loir, M., and M. Lanneau. 1984. Structural function of the basic nuclear proteins in ram spermatids. J 
Ultrastruct Res 86 (3):262-72. 
Longhese, M. P., D. Bonetti, I. Guerini, N. Manfrini, and M. Clerici. 2009. DNA double-strand breaks 
in meiosis: checking their formation, processing and repair. DNA Repair (Amst) 8 (9):1127-
38. 
Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. 
p53-dependent and independent expression of p21 during cell growth, differentiation, and 
DNA damage. Genes Dev 9 (8):935-44. 
Migliore, L., R. Colognato, A. Naccarati, and E. Bergamaschi. 2006. Relationship between genotoxicity 
biomarkers in somatic and germ cells: findings from a biomonitoring study. Mutagenesis 21 
(2):149-152. 
Ouhtit, A., H. K. Muller, D. W. Davis, S. E. Ullrich, D. McConkey, and H. N. Ananthaswamy. 2000. 
Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated 
mouse skin. Am J Pathol 156 (1):201-7. 
Pandir, D. 2015. Assessment of the DNA Damage in Human Sperm and Lymphocytes Exposed to the 
Carcinogen Food Contaminant Furan with Comet Assay. Brazilian Archives of Biology and 
Technology 58 (5):773-780. 
Perucca, P., O. Cazzalini, O. Mortusewicz, D. Necchi, M. Savio, T. Nardo, L. A. Stivala, H. Leonhardt, 
M. C. Cardoso, and E. Prosperi. 2006. Spatiotemporal dynamics of p21CDKN1A protein 
recruitment to DNA-damage sites and interaction with proliferating cell nuclear antigen. J 
Cell Sci 119 (Pt 8):1517-27. 
Pietsch, E. C., S. M. Sykes, S. B. McMahon, and M. E. Murphy. 2008. The p53 family and programmed 
cell death. Oncogene 27 (50):6507-21. 
Polo, S. E., and S. P. Jackson. 2011. Dynamics of DNA damage response proteins at DNA breaks: a 
focus on protein modifications. Genes Dev 25 (5):409-33. 
Pool-Zobel, B. L., R. G. Klein, U. M. Liegibel, F. Kuchenmeister, S. Weber, and P. Schmezer. 1992. 
Systemic genotoxic effects of tobacco-related nitrosamines following oral and inhalational 
administration to Sprague-Dawley rats. Clin Investig 70 (3-4):299-306. 
Pucci, Bruna, Margaret Kasten, and Antonio Giordano. 2000. Cell Cycle and Apoptosis. Neoplasia 
(New York, N.Y.) 2 (4):291-299. 
Purvis, J. E., K. W. Karhohs, C. Mock, E. Batchelor, A. Loewer, and G. Lahav. 2012. p53 Dynamics 
Control Cell Fate. Science 336 (6087):1440-1444. 
Russell, L. B., P. R. Hunsicker, N. L. Cacheiro, and E. M. Rinchik. 1992. Genetic, cytogenetic, and 
molecular analyses of mutations induced by melphalan demonstrate high frequencies of 
heritable deletions and other rearrangements from exposure of postspermatogonial stages 
of the mouse. Proc Natl Acad Sci U S A 89 (13):6182-6. 
Ryu, J. C., Y. R. Seo, M. L. Smith, and S. S. Han. 2001. The effect of methyl methanesulfonate (MMS)-
induced excision repair on p53-dependent apoptosis in human lymphoid cells. Res Commun 
Mol Pathol Pharmacol 109 (1-2):35-51. 
Sega, G. A., and J. G. Owens. 1983. Methylation of DNA and protamine by methyl methanesulfonate 
in the germ cells of male mice. Mutat Res 111 (2):227-44. 
Shanbhag, N. M., I. U. Rafalska-Metcalf, C. Balane-Bolivar, S. M. Janicki, and R. A. Greenberg. 2010. 
ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks. 
Cell 141 (6):970-81. 
Sionov, Ronit Vogt, Igal Louria Hayon, and Ygal Haupt. 2000. The regulation of p53 growth 
suppression. 
18 
 
Soussi, T., C. Caron de Fromentel, and P. May. 1990. Structural aspects of the p53 protein in relation 
to gene evolution. Oncogene 5 (7):945-52. 
Suwaki, N., K. Klare, and M. Tarsounas. 2011. RAD51 paralogs: roles in DNA damage signalling, 
recombinational repair and tumorigenesis. Semin Cell Dev Biol 22 (8):898-905. 
Tercero, J. A., and J. F. Diffley. 2001. Regulation of DNA replication fork progression through 
damaged DNA by the Mec1/Rad53 checkpoint. Nature 412 (6846):553-7. 
Tice, R. R., E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, H. Kobayashi, Y. Miyamae, E. Rojas, J. 
C. Ryu, and Y. F. Sasaki. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo 
genetic toxicology testing. Environ Mol Mutagen 35 (3):206-21. 
Tsai, A. G., and M. R. Lieber. 2010. Mechanisms of chromosomal rearrangement in the human 
genome. Bmc Genomics 11. 
Waxman, D. J., and P. S. Schwartz. 2003. Harnessing apoptosis for improved anticancer gene 
therapy. Cancer Res 63 (24):8563-72. 
Wulf, G. M., Y. C. Liou, A. Ryo, S. W. Lee, and K. P. Lu. 2002. Role of Pin1 in the regulation of p53 
stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J 
Biol Chem 277 (50):47976-9. 
Yu, Y., W. Zhu, H. Diao, C. Zhou, F. F. Chen, and J. Yang. 2006. A comparative study of using comet 
assay and gammaH2AX foci formation in the detection of N-methyl-N'-nitro-N-
nitrosoguanidine-induced DNA damage. Toxicol In Vitro 20 (6):959-65. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
Figure and table legends 
Table 1. Concentrations-response of MMS in human lymphocytes and sperm was 
measured using the alkaline Comet assay with the parameters Olive tail moment 
(OTM) and % tail DNA. Data shown represents group values (mean ± SE) of three 
experiments (100 cells per experiment). Ns not significant, *P < 0.05, **P < 0.01, 
***P < 0.001 versus control. 
Figure 1.  Comet assay results obtained from exposure of 0, 0.3, 0.6, 0.8 and 1.2 
mM concentrations of MMS to lymphocytes and sperm cells. Comet parameters, % 
tail DNA were taken into account to measure DNA damage showing a clear  
concentrations related increase in DNA damage. All experiments were performed at 
least three times. Mean values ± SE. * = comparison with negative control. *P < 
0.05, **P < 0.01, ***P < 0.001. 
Figure 2.  Comet assay results obtained from exposure of 0, 0.3, 0.6, 0.8 and 1.2 
mM concentrations of MMS to lymphocytes and sperm cells. Comet parameters, 
OTM were taken into account to measure DNA damage showing a clear 
concentrations related increase in DNA damage. All experiments were performed at 
least three times. Mean values ± SE. * = comparison with negative control. *P < 
0.05, **P < 0.01, ***P < 0.001. 
Figure 3. Concentration-dependent effects of MMS on TP53, CDKN1A, and BCL-2 
mRNA expression levels in lymphocyte cells, treated with different concentrations of 
MMS (0, 0.3, 0.6 and 1.2 mM) for 4 h. mRNA expression levels were determined by 
qPCR. β-actin mRNA was used as an internal control. (A) The relative gene 
expression level of TP53, CDKN1A, and BCL-2, analyzed from the qPCR results. (B) 
The mRNA of lysed cells was extracted and was converted to cDNA. The gene 
expression levels of TP53, CDKN1A, and BCL-2 were evaluated by reverse-
transcription PCR. β-actin mRNA was used as the internal control. The data shown 
are representative of three independent experiments. The significant differences 
from control are indicated by *P < 0.05, **P < 0.01, ***P < 0.001. 
Figure 4. Concentration-dependent effects of MMS on TP53, CDKN1A, and BCL-2 
mRNA expression levels in sperm cells, treated with different concentrations of MMS 
(0, 0.3, 0.6 and 1.2 mM) for 4 h. mRNA expression levels were determined by qPCR. 
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β-actin mRNA was used as an internal control. (A) The relative gene expression 
level of TP53, CDKN1A, and BCL-2, analyzed from the qPCR results. (B) The mRNA 
of lysed cells was extracted and was converted to cDNA. The gene expression levels 
of TP53, CDKN1A, and BCL-2 were evaluated by reverse-transcription PCR. β-actin 
mRNA was used as the internal control. The data shown are representative of three 
independent experiments. The significant differences from control are indicated by 
*P < 0.05, **P < 0.01, ***P < 0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
Table 1 
 
  
 
 
 
 
 
 
  
 
 
Different exposure concentrations of lymphocytes Olive Tail moment  Mean ±SE %Tail DNA  Mean ± SE   
Control 1.49 ± 0.14 7.65 ± 0.82 
0.3 mM 3.14 ± 0.46 14.97 ± 1.65 
0.6 mM 5.71 ± 0.84 * 22.42 ± 2.14 * 
0.8 mM 6.97 ± 1.21 ** 27.57 ± 2.36 * 
1.2 mM 11.00 ± 1.34 ** 36.71 ± 3.73 ** 
Different exposure concentrations of sperm Olive Tail moment  Mean ±SE %Tail DNA  Mean ± SE   
Control 4.93 ± 0.26 27.98 ± 1.69 
0.3 mM 6.28 ± 0.44 * 34.68 ± 0.54 * 
0.6 mM 8.44 ± 0.58 * 39.66 ± 2.85 ** 
0.8 mM 10.11 ± 0.43 ** 46.61 ± 2.13 ** 
1.2 mM 11.58 ± 0.14 *** 51.15 ±3.62 *** 
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Figure 2  
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
Control 0.3 mM MMS 0.6 mM MMS 0.8 mM MMS 1.2 mM MMS
%
 T
ai
l D
N
A
  
Methyl methanesulfonate (MMS) 
Lymphocyte
Sperm
 * 
 ** 
 ** 
*** 
 * 
 * 
 ** 
24 
 
Figure 3 
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Figure 4  
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